Dividends Calendar Earnings Calendar
SRPT

SRPT | Sarepta Therapeutics Inc

Sarepta Therapeutics Inc
Category: Company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 5.59B
  • Prev closed: 159.04
  • Open: 158.12
  • High: 158.38
  • Low: 148.31
  • 52 week low: 72.05
  • 52 week high: 175
  • Dividends:No Dividends

Next ER: May 5, 2021  After Market Closes



Top Stories (SRPT)

    About the Company

    Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 1, 2021-2.4 / -1.8145.14M / 150.38M
    November 5, 2020-2.5 / -1.71143.92M / 137.76MBeat!
    August 5, 2020-1.93 / -1.72137.36M / 116.29MBeat!
    May 6, 2020-0.23 / -1.92113.67M / 116.49M
    February 26, 2020-3.16 / -1.81100.11M / 98.8MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jun 7, 2021 76.81 72.97
    76.96
    72.50
    415.26K 5.26%
    Jun 4, 2021 72.97 73.92
    73.92
    72.21
    803.61K -1.07%
    Jun 3, 2021 73.76 75.51
    75.81
    73.58
    638.06K -2.25%
    Jun 2, 2021 75.46 75.73
    76.47
    74.62
    907.51K -0.26%
    Jun 1, 2021 75.66 76.01
    76.58
    73.89
    906.95K 0.01%
    May 28, 2021 75.65 76.86
    79.13
    75.49
    1.20M -1.57%
    May 27, 2021 76.86 74.54
    76.97
    73.35
    4.66M 2.55%
    May 26, 2021 74.95 75.59
    75.76
    73.81
    899.22K -0.2%
    May 25, 2021 75.10 76.66
    77.11
    74.50
    944.58K -2.73%
    May 24, 2021 77.21 79.76
    79.85
    76.73
    1.13M -2.98%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1980
    • Employees:743

    News

    News for (SRPT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Douglas S. Ingram
    • CFO :  Sandy Mahatme
    • General Counsel :  Ty Howton
    • Chief Medical Officer :  Gilmore O’Neill (R&D)

    Talk about Sarepta Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 5, 2021 (Same day)

    znga gm gddy ctsh pypl cern fox edit meli dnow apa cf 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 58
    HOLD 37
    SELL 5

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Other stocks 

    c asna gs dnow ash cmc mtb hlt arrs afsi lyb ntnx 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet